Meet Excel Life Sciences
It can take up to 10+ years to get a drug approved, with costs totaling over one billion dollars from start to finish. As you continue 4Q-2015 global clinical trials and business development activity and begin 2016 planning, challenges in recruitment, cost containment, choice of global site locations, and even market registration, are ever-present. This is especially true for oncology, cardiovascular, metabolic, and ophthalmic therapeutic areas.
To address these challenges, Excel Life Sciences can help you evaluate a Southeast Asia clinical research strategy as part of your global trials activity. We are a US-based, yet India-focused provider of comprehensive clinical trial management services. ELS is built around passionate and experienced individuals working alongside our clients to accelerate clinical research and delivery of new drugs and medical devices to the markets, while maintaining high standards of quality.
Dr. Vijai Kumar, President and Chief Medical Officer of ELS, can update you on a brief history / background of Indian regulations – with emphasis on why clinical trials is a new enterprise in India for 2016. Additionally, we will provide an overview of current regulatory approval, and review the rapidly growing Indian healthcare market for pharmaceutical products and medical devices.
After you submit the form, you will have the option to add this meeting request to your calendar.